Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Neurosurgery

Choosing Your Path: Observation, Surgery, or Radiosurgery

At a Glance

Vestibular schwannoma treatment includes observation, stereotactic radiosurgery, or microsurgery. No treatment can restore lost hearing; they only aim to preserve remaining hearing or stop tumor growth. The best option depends on tumor size, growth rate, and the patient's priorities.

Deciding on a management path for a vestibular schwannoma (VS) involves balancing the risks of the tumor against the potential side effects of treatment. There are three primary strategies: Observation (Wait-and-Scan), Stereotactic Radiosurgery (SRS), and Microsurgery.

A Critical Reality Check: Hearing “Restoration”

Before choosing a path, it is vital to understand one absolute rule: Neither surgery nor radiation can restore hearing that has already been lost. Treatments are designed to prevent further damage and attempt to preserve your remaining hearing [1].

The Three Paths of Management

1. Observation (Wait-and-Scan)

Many vestibular schwannomas grow very slowly or not at all. For patients with small tumors and few symptoms, doctors often recommend regular MRI scans and hearing tests rather than immediate treatment [2][3].

  • Best for: Small tumors—both intracanalicular and small extracanalicular tumors (typically up to about 1.5 cm or Koos Grade I/II)—older patients, or those with significant other health issues [4][5].
  • The Reality: While the tumor may remain perfectly stable, hearing decline can still occur even if the tumor does not grow. Stability of the tumor size does not guarantee the stability of your hearing [6][1]. If the tumor itself begins to grow quickly, active treatment becomes necessary [7].

2. Stereotactic Radiosurgery (SRS)

SRS, such as Gamma Knife, does not physically remove the tumor. Instead, it uses highly focused radiation beams to damage the tumor’s DNA, preventing it from growing further [8][9].

  • Best for: Small to medium tumors (typically under 2.5–3 cm) where the goal is long-term tumor control without the risks of open surgery [10][3].
  • Outcomes: SRS has excellent tumor control rates. It often offers better short-term hearing preservation compared to surgery [11][12]. However, over several years following radiation, your hearing can still gradually decline [13][1].

3. Microsurgery

This is the physical removal of the tumor by a neurosurgeon and/or an otolaryngologist.

  • Best for: Large tumors (Koos Grade III/IV), tumors causing brainstem compression, or younger patients who wish to avoid radiation [14][15].
  • Important Surgical Risks: While surgery is the only way to physically remove the tumor, it is a major skull-base procedure. It carries a risk of Cerebrospinal Fluid (CSF) leaks, which may require additional intervention to repair [15]. Additionally, surgeons may deliberately leave a tiny piece of the tumor behind (a subtotal resection) to avoid severing the facial nerve [16].
  • Surgical Approaches: The route the surgeon takes matters immensely. For instance, the Translabyrinthine approach involves drilling through the inner ear structures. By definition, this approach results in 100% permanent, total hearing loss in the affected ear [17].

Balancing Hearing and Facial Nerve Safety

The most significant concerns for most patients are the preservation of their hearing and the function of their facial nerve (which controls facial expressions, blinking, and smiling).

  • Understanding Facial Nerve Risk: When doctors discuss “facial nerve risk,” they mean weakness or paralysis of your facial muscles. This damage can be temporary (lasting weeks to months as the bruised nerve slowly heals) or, less commonly, permanent [18].
  • Protection During Surgery: During surgery, doctors use Intraoperative Monitoring (EMG). This provides real-time electrical feedback, warning the surgeon if the facial nerve is being stressed [19][18].
  • Hearing Preservation: If “serviceable” hearing exists, surgeons may use specific approaches and Auditory Brainstem Response (ABR) monitoring to try and save the hearing nerve during removal [20][17].

Recovery Timelines

  • Observation: No physical recovery time needed.
  • Radiosurgery (SRS): Generally an outpatient procedure. Most patients return to normal activities or work within 1 to 3 days [3].
  • Microsurgery: Typically requires 3 to 5 days in the hospital, followed by 4 to 6 weeks off work for home recovery [2].

Common questions in this guide

Can surgery or radiation restore the hearing I've already lost from my vestibular schwannoma?
No. Neither microsurgery nor stereotactic radiosurgery can restore hearing that has already been lost. These treatments are designed to prevent further damage and attempt to preserve the hearing you still have.
Is it safe to just watch and wait with a vestibular schwannoma?
Yes, observation or 'wait-and-scan' is often recommended for small tumors, especially in older patients. However, you should be aware that your hearing can still decline over time even if the tumor itself does not grow.
What is the difference between stereotactic radiosurgery and microsurgery?
Microsurgery involves a surgeon physically removing the tumor. Stereotactic radiosurgery, such as Gamma Knife, does not remove the tumor; instead, it uses highly focused radiation beams to damage the tumor's DNA and stop it from growing further.
Will I lose my hearing if I have vestibular schwannoma surgery?
Hearing outcomes depend heavily on the surgical approach and tumor size. For example, the translabyrinthine approach results in total, permanent hearing loss in the affected ear. Other approaches attempt to save the hearing nerve, but preservation is not guaranteed.
How do surgeons protect my facial nerve during vestibular schwannoma removal?
Surgeons use intraoperative monitoring (EMG) to track your facial nerve function in real-time during the procedure. In some cases, they may deliberately leave a tiny piece of the tumor behind to avoid permanently damaging the nerve.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my tumor size and growth rate, am I a candidate for 'Wait and Scan'?
  2. 2.What are your personal success rates for hearing preservation with microsurgery versus radiosurgery for a tumor of my size?
  3. 3.If I choose surgery, will you use continuous intraoperative monitoring for my facial and hearing nerves?
  4. 4.What is the risk of the tumor regrowing after radiosurgery versus the risk of incomplete removal during surgery?
  5. 5.How will each of these options likely affect my balance and dizziness in the long term?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Hearing Rehabilitation After Treatment of Sporadic Vestibular Schwannomas.

    Kumar S, Sahana D, Nair A, et al.

    Neurology India 2022; (70(3)):849-856 doi:10.4103/0028-3886.349600.

    PMID: 35864608
  2. 2

    Treatment planning for patients with acoustic neuroma.

    Fishman AJ, Rosiak O, Rivera A, et al.

    Frontiers in oncology 2025; (15()):1645881 doi:10.3389/fonc.2025.1645881.

    PMID: 41278265
  3. 3

    Management of Vestibular Schwannoma (Including NF2): Facial Nerve Considerations.

    Kaul V, Cosetti MK

    Otolaryngologic clinics of North America 2018; (51(6)):1193-1212 doi:10.1016/j.otc.2018.07.015.

    PMID: 30390772
  4. 4

    Radiologic Features of Spontaneous Regression of Vestibular Schwannomas.

    Vellutini EAS, Teles Gomes MQ, Brock RS, et al.

    World neurosurgery 2020; (135()):e488-e493 doi:10.1016/j.wneu.2019.12.034.

    PMID: 31843724
  5. 5

    De Novo Vestibular Schwannoma: A Report of Three Cases.

    Kubota M, Yamakami I, Kubota S, Higuchi Y

    NMC case report journal 2019; (6(2)):47-50 doi:10.2176/nmccrj.cr.2018-0188.

    PMID: 31016100
  6. 6

    Hearing loss and volumetric growth rate in untreated vestibular schwannoma.

    Gurewitz J, Schnurman Z, Nakamura A, et al.

    Journal of neurosurgery 2022; (136(3)):768-775 doi:10.3171/2021.2.JNS203609.

    PMID: 34416729
  7. 7

    Predictors of Growth of Vestibular Schwannoma After Gamma Knife Treatment: A Systematic Review.

    Yang C, Alvarado D, Ravindran PK, et al.

    Cancers 2025; (17(12)) doi:10.3390/cancers17121993.

    PMID: 40563642
  8. 8

    Stereotactic Radiosurgery in Primary Treatment of Sporadic Small to Medium (<3 cm) Vestibular Schwannomas: A Systematic Review and Meta-Analysis.

    Bonin BJ, Beckman S, Mahmud S, et al.

    World neurosurgery 2025; (194()):123304 doi:10.1016/j.wneu.2024.10.033.

    PMID: 39461420
  9. 9

    Tumor Control Following Stereotactic Radiosurgery in Patients with Vestibular Schwannomas - A Retrospective Cohort Study.

    Santa Maria PL, Shi Y, Aaron KA, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2021; (42(10)):e1548-e1559 doi:10.1097/MAO.0000000000003285.

    PMID: 34353978
  10. 10

    Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.

    Lo A, Ayre G, Ma R, et al.

    International journal of radiation oncology, biology, physics 2018; (100(2)):443-451 doi:10.1016/j.ijrobp.2017.09.024.

    PMID: 29066124
  11. 11

    Hearing Preservation, Facial Nerve Dysfunction, and Tumor Control in Small Vestibular Schwannoma: A Systematic Review of Gamma Knife Radiosurgery Versus Microsurgery.

    Aman RA, Petonengan DAA, Hafif M, Santoso F

    Journal of clinical neurology (Seoul, Korea) 2023; (19(3)):304-311 doi:10.3988/jcn.2022.0116.

    PMID: 36647227
  12. 12

    Audiovestibular symptoms and facial nerve function comparing microsurgery versus SRS for vestibular schwannomas: a systematic review and meta-analysis.

    Yakkala VK, Mammi M, Lamba N, et al.

    Acta neurochirurgica 2022; (164(12)):3221-3233 doi:10.1007/s00701-022-05338-z.

    PMID: 35962847
  13. 13

    Rate of Hearing Preservation After Stereotactic Radiosurgery for Treatment of Vestibular Schwannoma: Analysis of Patients With 100% Word Recognition Scores.

    Vargas H, Khandalavala KR, Marinelli JP, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2026; (47(4)):630-633 doi:10.1097/MAO.0000000000004844.

    PMID: 41612570
  14. 14

    Koos Classification of Vestibular Schwannomas: A Reliability Study.

    Erickson NJ, Schmalz PGR, Agee BS, et al.

    Neurosurgery 2019; (85(3)):409-414 doi:10.1093/neuros/nyy409.

    PMID: 30169695
  15. 15

    Vestibular schwannoma microneurosurgery in patients over 70: a single institution experience and proposal of a treatment algorithm.

    Michelini S, Campione A, Carpineta E, et al.

    Neurosurgical review 2024; (47(1)):410 doi:10.1007/s10143-024-02615-6.

    PMID: 39117744
  16. 16

    Evolving Role of Non-Total Resection in Management of Acoustic Neuroma in the Gamma Knife Era.

    Luryi AL, Kveton JF, Babu S, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2020; (41(10)):e1354-e1359 doi:10.1097/MAO.0000000000002904.

    PMID: 33492813
  17. 17

    Intraoperative Continuous Neuromonitoring for Vestibular Schwannoma Surgery: Real-Time, Quantitative, and Functional Evaluation.

    Matsushima K, Kohno M, Sakamoto H, et al.

    World neurosurgery 2022; (158()):189 doi:10.1016/j.wneu.2021.11.102.

    PMID: 34861446
  18. 18

    Intraoperative monitoring and early recognition of facial nerve root in vestibular schwannoma surgery.

    Keswani R, Perkasa SAH, Nurlita D, et al.

    Neurosurgical review 2024; (47(1)):798 doi:10.1007/s10143-024-03017-4.

    PMID: 39402283
  19. 19

    [Vestibular Schwannoma Surgery with Continuous Intraoperative Monitoring of Evoked Facial Nerve Electromyograms].

    Akazawa A, Kodera T, Awara K, et al.

    No shinkei geka. Neurological surgery 2018; (46(7)):593-598 doi:10.11477/mf.1436203775.

    PMID: 30049900
  20. 20

    Intraoperative Hearing Monitoring Using ABR and TT-ECochG and Hearing Preservation during Vestibular Schwannoma Resection.

    Niemczyk K, Pobożny I, Bartoszewicz R, Morawski K

    Journal of clinical medicine 2024; (13(14)) doi:10.3390/jcm13144230.

    PMID: 39064270

This page provides educational information on vestibular schwannoma treatment options and recovery. It does not replace professional medical advice from your neurosurgeon or otolaryngologist.

Get notified when new evidence is published on Vestibular schwannoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.